Legal, Regulatory, Patent & ANDA Liability Disclaimer
1. Public Domain Data & Non-Affiliation with NDA/ANDA Holders: All reference drug data displayed within FormulAI is sourced exclusively from publicly accessible government registries, including the U.S. FDA DailyMed Structured Product Labeling (SPL) repository, the FDA Orange Book, the FDA Inactive Ingredient Database (IID), and published pharmacopeial monographs (USP/NF, Ph.Eur., IP). FormulAI and Pehel Specialities LLP have no access to confidential, non-public, or proprietary NDA, ANDA, or DMF quantitative dossiers. Any quantitative % w/w or mg/tablet compositions generated by this platform are independent, first-principles mathematical estimates derived from general-purpose powder physics (SeDeM) and statistical optimization algorithms, and do not represent the actual proprietary quantitative formula or manufacturing process of any marketed Reference Listed Drug (RLD) or approved generic product. All third-party product names, trademarks, NDA/ANDA numbers, and company names remain the property of their respective owners and are referenced strictly under nominative fair use for scientific identification only.
2. No Freedom-to-Operate (FTO) Opinion & Anti-Infringement Notice: Output from FormulAI does not constitute a patent clearance, Freedom-to-Operate (FTO) opinion, or legal advice, nor does Pehel Specialities LLP encourage, induce, or authorize the infringement of any active composition-of-matter, formulation, polymorph, dosage-form, or process patent in any jurisdiction (except where protected by statutory research exemptions such as the Hatch-Waxman Safe Harbor under 35 U.S.C. § 271(e)(1) or Section 107A of the Indian Patents Act, where applicable). Users and their organizations are solely and exclusively responsible for conducting independent patent landscape and FTO analyses prior to laboratory testing, scale-up, ANDA/505(b)(2) filing, or commercialization.
3. “As-Is” R&D Decision Support & Zero Liability: FormulAI is an in-silico pre-formulation modeling tool provided “as-is” without warranties of any kind. Theoretical predictions do not replace physical cGMP wet-lab testing, ICH stability studies, or bioequivalence trials. Users and their organizations remain solely responsible for conducting independent wet-lab verification, physical compatibility and stability testing, cGMP compliance, and all required regulatory filings (including FDA, EMA, CDSCO, and ICH guidelines) prior to clinical or commercial manufacturing. Pehel Specialities LLP assumes no liability for batch failures, patent infringement, or regulatory outcomes resulting from the use of this software. To the maximum extent permitted by law, Pehel Specialities LLP, its partners, and officers disclaim all liability for any direct, indirect, regulatory, commercial, or intellectual-property claims, batch failures, or damages arising from the use of this platform.